TORRENT DO BRASIL LTDA — Rivaroxaban Importer Profile
Pharmaceutical Importer · #11 buyer for Rivaroxaban · $980.6K import value · 32 shipments · BRAZIL · DGFT Verified
TORRENT DO BRASIL LTDA is the #11 importer of Rivaroxaban from India with $980.6K in import value and 32 verified shipments. TORRENT DO BRASIL LTDA holds a 1.3% market share in Rivaroxaban imports based in BRAZIL. The company sources from 1 verified supplier across 25 formulations shipped to 1 country. Overall, TORRENT DO BRASIL LTDA imports 6 pharmaceutical products worth $29.0M across 4 therapeutic categories.
TORRENT DO BRASIL LTDA — Rivaroxaban Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Rivaroxaban to TORRENT DO BRASIL LTDA?
Verified from 32 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| TORRENT PHARMACEUTICALS LIMITED | $980.6K | 32 | 100.0% |
TORRENT DO BRASIL LTDA sources Rivaroxaban from 1 verified Indian supplier based on 32 customs records. The primary supplier is TORRENT PHARMACEUTICALS LIMITED accounting for 100.0% of imports.
How Does TORRENT DO BRASIL LTDA Compare to Nearest Rivaroxaban Importers?
Buyers ranked immediately above and below #11 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 7 | MYLAN IRELAND C/O ALLOGA RDC,. | NETHERLANDS | $911.1K | 46 | $19.8K |
| 9 | BIOLAB FARMA GENERICO | BRAZIL | $750.0K | 15 | $50.0K |
| 11 | TORRENT DO BRASIL LTDA ★ | BRAZIL | $688.7K | 20 | $34.4K |
| 12 | MYLAN IRELAND | NETHERLANDS | $653.5K | 33 | $19.8K |
| 10 | GMP MANUFACTURING LTD | UNITED KINGDOM | $600.0K | 12 | $50.0K |
TORRENT DO BRASIL LTDA ranks #11 among 497 Rivaroxaban importers from India. Average shipment value of $34.4K compared to the market average of $33.2K. The closest competitors by value are MYLAN IRELAND C/O ALLOGA RDC,. and BIOLAB FARMA GENERICO.
Where Does TORRENT DO BRASIL LTDA Import Rivaroxaban To?
Destination countries from 32 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| BRAZIL | $980.6K | 32 | 100.0% |
TORRENT DO BRASIL LTDA imports Rivaroxaban to 1 country. The primary destination is BRAZIL receiving 100.0% of shipments worth $980.6K.
What Rivaroxaban Formulations Does TORRENT DO BRASIL LTDA Import?
| Formulation | Value | Shipments |
|---|---|---|
| OTHER-ACOG 15 MG TABLETS ( RIVAROXABAN 15 MG TABLETS ) NOS SIZE 3 X 10 TABLETS | $108.4K | 3 |
| OTHER-RIVAROXABAN 20 MG TABLET RIVAROXA | $100.0K | 2 |
| OTHER - ACOG 15MG TABLETS (RIVAROXABAN 1 | $77.0K | 2 |
| OTHER-RIVAROXABAN 10 MG TABLET RIVAROXA | $74.1K | 2 |
| OTHER-RIVAROXABAN 20MG TABLET (RIVAROXAB | $50.0K | 1 |
| OTHER - RIVAROXABAN 20MG TABLET (RIVAROX | $50.0K | 1 |
| OTHER- ACOG 20 MG TABLETS (RIVAROXABAN 20 MG TABLETS) NOS SIZE 3 X 10 TABLETS | $50.0K | 1 |
| RIVAROXABAN 15 MG TABLET (RIVARDOXABAN 1 | $45.8K | 1 |
| OTHER-RIVAROXABAN 15MG TABLET (RIVAROXAB | $43.8K | 1 |
| OTHER - ACOG 20 MG TABLETS ( RIVAROXABAN20 MG TABLETS ) NOS SIZE 3X10 TABLETS | $43.0K | 1 |
TORRENT DO BRASIL LTDA imports 25 distinct Rivaroxaban formulations from India. The top formulation is OTHER-ACOG 15 MG TABLETS ( RIVAROXABAN 15 MG TABLETS ) NOS S with 3 shipments worth $108.4K.
Regulatory Requirements: Importing Rivaroxaban into Brazil
What TORRENT DO BRASIL LTDA and other importers must comply with to import Rivaroxaban from India
Regulatory Authority
Brazilian Health Regulatory Agency (ANVISA)
Approval Process for Generic Rivaroxaban
Generic drug registration under RDC 200/2017. Requires pharmaceutical equivalence and bioequivalence studies. ANVISA GMP inspection of overseas facilities mandatory.
Typical timeline: 12–24 months
GMP Requirements
ANVISA GMP certificate (CBPF) for each manufacturing site; on-site inspection by ANVISA
Import Licence & Documentation
Import Authorization (LI) via SISCOMEX; Sanitary Import Permit from ANVISA
Labeling & Packaging
Portuguese language labeling mandatory; ANVISA registration number
Note: ANVISA maintains an active inspection program for Indian pharma facilities. Inspection backlog can extend timelines significantly.
Regulatory information is provided for general reference based on publicly available ANVISA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with ANVISA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Rivaroxaban from India and How Much Does TORRENT DO BRASIL LTDA Import?
India exported $16.5M worth of Rivaroxaban through 5,361 shipments from 221 suppliers to 115 countries, serving 497 buyers globally. TORRENT DO BRASIL LTDA imports $980.6K of this total, accounting for 1.3% of India's Rivaroxaban exports with 32 shipments from BRAZIL. This is verified from 32 customs shipment records covering 25 distinct formulations.
What Is the Average Order Value for TORRENT DO BRASIL LTDA's Rivaroxaban Imports?
TORRENT DO BRASIL LTDA's average Rivaroxaban order value is $30.6K per consignment, based on 32 shipments totaling $980.6K. TORRENT DO BRASIL LTDA is based in BRAZIL and ranks #11 among all Rivaroxaban importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Rivaroxaban to TORRENT DO BRASIL LTDA?
TORRENT DO BRASIL LTDA sources Rivaroxaban from 1 verified Indian supplier: TORRENT PHARMACEUTICALS LIMITED ($980.6K, 100.0%). This is based on 32 customs records.
How Does TORRENT DO BRASIL LTDA Compare to Other Rivaroxaban Importers?
TORRENT DO BRASIL LTDA ranks #11 among 497 Rivaroxaban importers from India with a 1.3% market share. The top 3 importers are MYLAN IRELAND C/O ALLOGA RDC, ($4.2M), PHARMADOX HEALTHCARE LTD ($3.9M), APOTEX INC ($1.3M). TORRENT DO BRASIL LTDA processed 32 shipments from BRAZIL.
What Other Cardiovascular Products Does TORRENT DO BRASIL LTDA Import?
TORRENT DO BRASIL LTDA also imports these cardiovascular products. Each links to the detailed product page.
About TORRENT DO BRASIL LTDA
TORRENT DO BRASIL LTDA imports 6 products worth $29.0M. Beyond Rivaroxaban, top products include Rosuvastatin, Gliclazide, Calcium, Bisoprolol, Sertraline. View the complete TORRENT DO BRASIL LTDA profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Rivaroxaban — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Rivaroxaban shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: TORRENT DO BRASIL LTDA matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as TORRENT DO BRASIL LTDA's capped import value divided by total capped export value for Rivaroxaban across all Indian exporters.
- 5.Verified Records: This page is backed by 32 individual customs records matching TORRENT DO BRASIL LTDA importing Rivaroxaban, covering 25 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 115+ countries, 497+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Rivaroxaban Import Data for TORRENT DO BRASIL LTDA
Access order-level details, pricing data, supplier connections, and competitive analysis for TORRENT DO BRASIL LTDA's Rivaroxaban imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
TORRENT DO BRASIL LTDA
Full Company Profile →
6 products · $29.0M total trade · 4 categories
TORRENT DO BRASIL LTDA × Rivaroxaban
Verified from customs records
Company Overview
Top Products by TORRENT DO BRASIL LTDA
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for TORRENT DO BRASIL LTDA.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Rivaroxaban. For current order-level data, contact TransData Nexus.